In a recent study in mice, researchers combined tumor barcoding with unbiased genomic analysis and identified Cd109 as a hub gene involved in metastatic progression. They show that pharmacological inhibition of its downstream effectors JAK1 and STAT3 curtails metastatic growth.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Howlader, N. et al. (eds). SEER Cancer Statistics Review, 1975–2013 (National Cancer Institute, Bethesda, 2016). http://seer.cancer.gov/csr/1975_2013/.
Janku, F., Stewart, D.J. & Kurzrock, R. Nat. Rev. Clin. Oncol. 7, 401–414 (2010).
Chuang, C.-H. et al. Nat. Med. 23, 291–300 (2017).
Fidler, I.J. Semin. Cancer Biol. 21, 71 (2011).
Chambers, A.F., et al. Surg. Oncol. Clin. N. Am. 10, 243–255 (2001).
Bhang, H.E. et al. Nat. Med. 21, 440–448 (2015).
Kumar, A. et al. Nat. Med. 22, 369–378 (2016).
Hosseini, H. et al. Nature 540, 552–558 (2016).
Eyles, J. et al. J. Clin. Invest. 120, 2030–2039 (2010).
Harper, K.L. et al. Nature 540, 588–592 (2016).
Rhim, A.D. et al. Cell 148, 349–361 (2012).
Zheng, G.X. et al. Nat. Commun. 8, 14049 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Pisarsky, L., Dai, J. & Ghajar, C. Taking inventory of metastasis effectors. Nat Med 23, 275–276 (2017). https://doi.org/10.1038/nm.4301
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4301
